BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML
{{output}}
Myelodysplastic syndrome and acute myeloid leukemia (AML) belong to a continuous disease spectrum of myeloid malignancies with poor prognosis in the relapsed/refractory setting necessitating novel therapies. Natural killer (NK) cells from patients with myeloid... ...
